Pulse Biosciences, Inc. (PLSE)
NCM · Common · CUSIP 74587B101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PLSE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
74587B101
Market Cap
Small Cap
IPO
$4.00/share
Business: Pulse Biosciences, Inc. is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients. If cleared, the CellFX® System will be the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation™ (NPS) technology to treat a variety of applications for which an optimal solution remains unfulfilled. NPS technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

Company Contact

CEO
Paul LaViolette
CFO
Jon Skinner
Headquarters
601 Brickell Key Drive, Miami, FL 33131
Phone
510-906-4600 · Toll-Free 833-257-3393
Investor Relations
Sandra Gardiner · 510-241-1077 · ir@pulsebiosciences.com
General Email
info@pulsebiosciences.com
SEC EDGAR Filings
View filings »